Use of whole-genome sequencing data to analyze 23S rRNA-mediated azithromycin resistance

Int J Antimicrob Agents. 2017 Feb;49(2):252-254. doi: 10.1016/j.ijantimicag.2016.10.023. Epub 2016 Dec 19.

Abstract

The whole-genome sequences of 24 isolates of Neisseria gonorrhoeae with elevated minimum inhibitory concentrations (MICs) to azithromycin (≥2.0 µg/mL) were analyzed against a modified sequence derived from the whole-genome sequence of N. gonorrhoeae FA1090 to determine, by signal ratio, the number of mutant copies of the 23S rRNA gene and the copy number effect on 50S ribosome-mediated azithromycin resistance. Isolates that were predicted to contain four mutated copies were accurately identified compared with the results of direct sequencing. Fewer than four mutated copies gave less accurate results but were consistent with elevated MICs.

Keywords: 23S rRNA; Azithromycin; Neisseria gonorrhoeae; Resistance.

MeSH terms

  • Anti-Bacterial Agents / pharmacology*
  • Azithromycin / pharmacology*
  • DNA, Bacterial / chemistry
  • DNA, Bacterial / genetics*
  • DNA, Ribosomal / chemistry
  • DNA, Ribosomal / genetics*
  • Drug Resistance, Bacterial
  • Gene Dosage
  • Genome
  • Microbial Sensitivity Tests
  • Neisseria gonorrhoeae / drug effects*
  • Neisseria gonorrhoeae / genetics
  • Neisseria gonorrhoeae / isolation & purification
  • Point Mutation
  • RNA, Ribosomal, 23S / genetics*
  • Sequence Analysis, DNA*

Substances

  • Anti-Bacterial Agents
  • DNA, Bacterial
  • DNA, Ribosomal
  • RNA, Ribosomal, 23S
  • Azithromycin